You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KALV Disposition Disclosure
Yea Christopher · SEC Form 4 · Filed Jun 11, 2026
Disposition
Reported value range
Not reported
Yea Christopher Chief Development Officer
KALV
Transaction date
Jun 11, 2026
Public filing date
Jun 11, 2026
Filing lag
Filed same day
KALV daily price context
Close on/before transaction
$27
Jun 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 52,600 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001691102-26-000009
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kalvista Pharmaceuticals, Inc. KALV Current | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | $0 |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |